Gate Pass Capital, LLC Abbott Laboratories Transaction History
Gate Pass Capital, LLC
- $173 Billion
- Q3 2025
A detailed history of Gate Pass Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Gate Pass Capital, LLC holds 3,346 shares of ABT stock, worth $432,503. This represents 0.26% of its overall portfolio holdings.
Number of Shares
3,346
Previous 3,351
0.15%
Holding current value
$432,503
Previous $456 Million
1.67%
% of portfolio
0.26%
Previous 0.3%
Shares
4 transactions
Others Institutions Holding ABT
# of Institutions
3,639Shares Held
1.37BCall Options Held
9.55MPut Options Held
8.28M-
Vanguard Group Inc Valley Forge, PA173MShares$22.4 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$10.1 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA61.6MShares$7.96 Billion1.4% of portfolio
-
Capital Research Global Investors Los Angeles, CA38.8MShares$5.01 Billion1.02% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $226B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...